chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ate breakfast and lunch.  Slight nausea, headache, fatigue started Sunday 2/21/2021 around 2:00 pm..  Slept the rest of the day, off and on.  Ate one piece dry toast and drank water.  Monday, 2/22/2021 got up and felt fine.
After the vaccines lost temperature they were administered; A spontaneous report was received from a healthcare professional concerning a 65-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, after the vaccines lost temperature they were administered.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, a refrigerator in a vaccine clinic lost power and rose up to room temperature overnight. At approximately 9 p.m., the vaccines inside the refrigerator reached room temperature.  On 12 Jan 2021, after the vaccine lost temperature, the patient received their first of two planned doses of mRNA-1273 (Lot number: 027L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  No treatment information was provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The event, after the vaccines lost temperature they were administered, was considered resolved on 12 Jan 2021.; Reporter's Comments: This report refers to a case of product storage error for mRNA-1273, lot # 027L20A. There were no reported AEs associated with this case of product storage error.; Sender's Comments:  MOD-2021-003111: MOD-2021-003090: MOD-2021-003082:
Immediately after the vaccination, patient reported feeling an itchy face + arms, tired, and dry throat. Well appearing at time of incident. No rashes.
No adverse reactions reported.   To whom it may concern: In November 2022 our Vaccine program did our every-other-year audits in both of our offices. It was discovered at that time, that some Covid Vaccines were administered outside of the 10 week expiration date (which is calculated from the date the vaccines were received.) The Program directed us to fill out VAERS forms and send them to you. They also counselled us that it was our providers and parents joint decision as to whether to re-vaccinate pts or not.  We only use Pfizer vaccines for Covid - and the listed lot #'s given outside the expiration date are listed below.  Location #1 FM0698 (orange top) FM0698 (purple top) FL8095 (orange top) FL8094 (orange top) FM7553 (purple)  Location #2 FM0698 (purple) FP4554 (purple) FL8094 (orange) FL8095 (orange) FT1551 (orange)  Please see the attached VAERS forms, and feel free to contact the office for further questions or concerns.
I started to get a really bad head ache body aches I couldn't move, fever and chills body aches stopped me from moving , I was that way till around 5 or 6am the next morning, I was still achy but I could moving I still had body aches but I as able to move better
7 weeks 5 days pregnant when shot was administered baby died at 8 weeks 5 days. Immediately felt terrible after injection.
Patient complains of severe body pain and aches the morning and day following SHINGRIX vaccine.
4/15/2021: Severe headache, hip/joint pains, Nausea & vomiting. Mobility & balance issues, unable to walk or stand, tinnitus & extreme fatigue, change is mental status. *tinnitus, fatigue, nauseous feeling and balance problem & sudden depressed feeling continuous for weeks. 5/20/2021: severe neck pain and neck stiffness. Fatigue, nausea, tinnitus, confusion & mood changes
Pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 30-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Patient reported having no health conditions or allergies.). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Prenatal care.    On 06-Apr-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-May-2021. On 06-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). On 06-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
already more than 42 days since their 1st Dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. /unknown.  Concomitant product use was not provided/unknown by the reporter.
Gave Expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave Expired vaccine) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 067H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave Expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave Expired vaccine) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-590501 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-590501:Master case
Days 1-3: Headache, nausea, weakness, low-grade fever, chills, limited neck movement, limited left arm movement, bone pain in both legs and hips, full back pain Days 4-6: Headache, nausea, fatigue and poor activity tolerance Days 7-9: Hives/rash first appeared on upper arms, then progressed to lower arms and neck. Hives increased to mid and upper back, and both legs. Leg rash not raised, look like petechiae. Pruritus most severe in shoulders, neck, back.
Patient received an expired vaccine based on the storage guidelines outlined by Pfizer. The vaccine expired on 9/30/22.  Pfizer does not have any data or studies to determine the effectiveness of the expired vaccine. Based on the guidance received from Pfizer, it is recommended that the patient continue with her primary series and complete the series on the normal timeline.
pt devel flu-like sx including fever 101, cough, difficulty breathing approx 1 & 1/2 mon p/recvd flu vax; tx Keflex;
Chills, Fever (99.2)(took 2 Tylenol at 2:20 pm 04/23/2021), Body Aches, Headache, Nausea
30 minutes after receiving the vaccination she reported feeling dizzy and not right. She leaned herself forward in her chair saying I don't feel good. She then attempted to through herself onto the floor. She was assisted to the ground. On the way down to the floor she kept saying I don't feel good. Once on the floor she continued to speak and started to shake her whole body around, kicking her legs about and flailing her arms and shaking her head. She initially was speaking then she stopped speaking and alternated between having her eyes open and her eyes closed. She shook for about 30 seconds then she stopped but she did not speak for about 5 minutes. She shook intermittently shake briefly when someone tried to speak to her or take her vital signs.
Redness, heat, and sweeling at the injection site on 11-2-04 C/o Headache on 11-1-04 at 3:30pm Nausea and vomiting excitable affect and slight confusion
Pt developed rash in several spots on his body started at his back , his arms then his legs, rash started 2 days after getting the moderna vaccine.
Mom of patient came in to speak with clinic manager regarding the HPV vaccine that patient received on 8/8/2019. Mom states that 11 days later patient had a rash, and some time after that was diagnosed with Pots Syndrome. Mom of patient wanted to report the vaccine as she believes this is directly related to that HPV vaccine the patient received.
I have a  large, rectangular red patch of skin surrounding the injection site.  It's warm to the touch and area feels like a was punched.  Delayed reaction to injection perhaps as the only reaction I had initially, was a soreness at injection site.
Became listless, felt very hot, had 3 jerking episodes close to MN; took to ER just a/MN;
Body aches, headache, fatigue.  Resolved 10/28/2021.
The patient presents with Right sided weakness, onset 1400 this afternoon. Pt coming was noted to be experiencing worsening symptoms. EMS services were called and pt was noted to be febrile with a HR of 140 at arrival.  Pt denies headache, altered vision, dizziness, chest pain, shortness of breath, urinary symptoms, and all other symptoms.  The onset was 1400 today. Associated symptoms: denies chest pain, denies abdominal pain, denies nausea, denies vomiting, denies shortness of breath, denies chills, denies headache, denies dizziness and denies back pain.   Patient was tested 2 days ago for COVID-19 and tested negative. ? CVA--Covid incidental finding asymptomatic
Client reports approx 24hr (Tuesday) after vaccination red rash, swelling, itching, warmth noted to injection site. Took Tylenol and used ice pack at this time. Client called Health Department Friday morning regarding symptoms, instructed to visit for nurse to assess. Client arrives, reports site looks improved from yesterday. Assessment: local reaction 70mmx 70mm erythema circle surrounding injection site, very light pink with  slightly darker pink border. Slight swelling and increased warmth noted to affected area. Tenderness reported as dully/ achy with movement only. Denies any other symptoms. Instructed PRN Tylenol  use for discomfort (unable to take NSAID's d/t hx of ulcers), Benadryl and ice pack. Use affected arm per norm. If symptoms worsen call PCP.  F/u apt with nurse scheduled for Monday (5-23) Client arrived to Health Department for assessment of affected area, completely resolved of erythema, swelling, warmth and tenderness. Client denies any other symptoms or issues. Encouraged to call with any questions.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 12:08 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 12:08 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 32.13. Concomitant products were not provided. Treatment medications were not reported.  Batch number 007C21A underwent temperature excursion on 27-Apr-2021 with temperature 35 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 19-Apr-2021 and beyond use date for the vial was reported as 19-May-2021. Product moved to clinic on 27-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.   This case was linked to MOD-2022-566976 (Patient Link).
patient's wife reported that patient has a rash on both sides of his back on either side of the spine. has been there since he received the vaccine on 3/13/21. said she had been treating with oral over the counter benadryl but rash still present. patient's wife also states that he is now experiencing an "itching" sensation on his finger tips. she states almost nerve like. I instructed patient's wife to contact his doctor and that I would report the adverse reaction.
Fatigue/headache/body malaise one hour after 2nd dose of COVID 19 vaccine.  Now c/o (L) arm pain radiating to (L) elbow/(L) leg pain/dizziness/diaphoresis weakness to (L) lower extremity.
States 1-2 weeks after taking the Jansen vaccine he began having pain in the bilateral elbows, knees and ankles. Seen 5-28-21 given acetaminophen BID x 3 days.. 6-11-21 Ordered Ibuprofen 600mg BID x 10 days.   6-15-21 given Kenalog 40mg IM. 6-16-21: ordered Prednisone 20mg daily x 6 days.
dry cough (severe), patient has history idiopathic pulmonary fibrosis/chronic hypoxic respiratory failure on 2 L of home O2, was taking 2 weeks course of prednisone taper (finished on 3/28/31)
24 hrs p/vax had episode of fussiness, cried several hrs; fever up to 104 29NOV & 30NOV; 2NOV woke from nap screaming; seen in clinic by MD cried almost uncontrolably; mom was able to console if held; no fever 2NOV; 4NOV pt behaving nl;
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 65 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hyperlipidemia" (unspecified if ongoing); "asthma" (unspecified if ongoing); "highncholestrol" (unspecified if ongoing), notes: other medical history: highncholestrol. Concomitant medication(s) included: LIPITOR, start date: Jan2012; LANSOPRAZOLE, start date: Jan2012. Past drug history included: Ibuprofen, reaction(s): "known allergies Ibuprofen", notes: known allergies: Ibuprofen. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (unspecified date) positive, notes: COVID 19 Treatment; (02Jan2023) positive, notes: positive antibody test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
30 weeks pregnant; received Moderna vaccine 1st dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant; received Moderna vaccine 1st dose) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Sep-2020 and the estimated date of delivery was 15-Jun-2021. On 08-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant; received Moderna vaccine 1st dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  On 08-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant; received Moderna vaccine 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Oct-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
Anaphylaxis.  Epi Pen given and ambulance called.  Given anaphylaxis cocktail in ER. 2:30pm:  Vaccine administered 3:30pm:  Headache & teeth ache which continued 7:00pm  asthmatic cough which continued throughout 11:00pm  fever and chills 9:00am  felt generally very ill--stomach pain (more anaphylactic type pain) 10:00am nausea, severe stomach pain, diarreaha, vomiting, lungs very tight, continued coughing 11:00am  excruciating stomach pain (stomach on fire)  Throat felt "thick", feeling faint, brain fog, dizzy  (These are my typical anaphylactic reactions) Epi pen administered & ambulance called Anaphylaxis symptoms returned in ER.   The pain was the worst since my bowel obstructions several years ago.
Both of my eyes swelled and I had a subconjunctival hemorrhage in my left eye that covered 3/4 of my eye and my eye was so swollen it was almost closed.  The blood from the hemorrhage moved under my skin like a bruise over my cheek bone and across my nose and felt my face burning for over an hour. The under skin hemorrhage dissipated after about 15 minutes and then I could feel blood running down my throat and could taste it.  A severe headache started just a few minutes after the hemorrhage.  I have also experienced other normal  Covid vaccine symptoms and became very sick from them, Both of my are sore and still swollen and still a have a bloody eye 2 days later.
This spontaneous prospective pregnancy report as received from a medical assistant refers to a 20 year old female patient. The patient had no pertinent medical history nor drug reactions/allergies. On 14-NOV-2013 the patient was vaccinated with VARIVAX (Merck) (0.5 ml, subcutaneous, dose number unknown; lot number reported as J005430 Exp 02-May-2015). No concomitant therapies were reported. It was reported that on 14-NOV-2013 the patient came in for a VARIVAX (Merck) vaccination for college. At the same visit the patient mentioned to the physician that she had been having morning sickness, feeling uncomfortable, and has had some abdominal pain. A Urine Pregnancy test was taken at the office and was positive. Other blood work was also performed on that same day. The patient sought medical attention. Additional information has been requested.
Client left clinic area, while in parking lot fainted/shaking and became incontinent of urine, via ambulance to hospital.
Pt stated that he has had swelling, tingling, and pain up and down his arm.  He is also reporting mild pain down one side of his chest which is not going away.  The second shot of Moderna was give 05-03-2021.
ACUTE MI HYPOTENSION 10/16/2022, 12/2/2022,  12/19/2022,  2/13/2023,  2/4/2023,  1/22/2023 -- RECURRENCE OF SAME SYMPTOMS
Post vax, the pt developed a slightly raised rash on neck, abdomen, and most of her body with itching.
blood clot in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clot in the right arm) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003c21A and 012a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clot in the right arm). At the time of the report, THROMBOSIS (blood clot in the right arm) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded. This is a non-serious event, however, medical history, con meds, details regarding the type of clot, tests/diagnostics and treatment are required for further assessment.
This employee says his arm became hot and inflamed after given the Moderna COVID19 vaccine. This left upper extremity was red  in color. He asked this on site nurse for advice and I told him to be seen by a provider. He was diagnosed with cellulitis and given two scripts.
Quarter size redness at injection site, moderate muscle aches in injection arm, swollen axillary lymph nodes in injection arm, difficulty lifting injection arm, chills, moderate fatigue.
Diarrhea and nausea onset at 4:30pm on day of vaccine, 3/1/2021. Headache onset at 6:30am the following morning, 3/2/2021.
This spontaneous report as received from a other health professional refers to a 2 year old patient. On 07-AUG-2014 the patient was vaccinated with M-M-R II (lot # H011885, expiration date: 25-JUN-2014) 0.5 ml, subcutaneously, which was expired. This is one of several reports received from the same source. Additional information has been requested.